Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oppenheimer Holdings (OPY) Other Operating Expenses: 2010-2025

Historic Other Operating Expenses for Oppenheimer Holdings (OPY) over the last 16 years, with Sep 2025 value amounting to $350.9 million.

  • Oppenheimer Holdings' Other Operating Expenses rose 18.09% to $350.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 13.98%. This contributed to the annual value of $1.2 billion for FY2024, which is 11.37% up from last year.
  • Latest data reveals that Oppenheimer Holdings reported Other Operating Expenses of $350.9 million as of Q3 2025, which was up 17.28% from $299.2 million recorded in Q2 2025.
  • Oppenheimer Holdings' Other Operating Expenses' 5-year high stood at $350.9 million during Q3 2025, with a 5-year trough of $207.9 million in Q2 2022.
  • Moreover, its 3-year median value for Other Operating Expenses was $278.7 million (2023), whereas its average is $285.7 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first spiked by 51.33% in 2021, then declined by 24.47% in 2022.
  • Quarterly analysis of 5 years shows Oppenheimer Holdings' Other Operating Expenses stood at $237.4 million in 2021, then climbed by 3.86% to $246.6 million in 2022, then rose by 1.60% to $250.6 million in 2023, then rose by 26.35% to $316.6 million in 2024, then grew by 18.09% to $350.9 million in 2025.
  • Its last three reported values are $350.9 million in Q3 2025, $299.2 million for Q2 2025, and $284.3 million during Q1 2025.